ArticleMedicina (Kaunas, Lithuania)2026
Prognostic Value of the Modified Glasgow Prognostic Score in Patients with Metastatic Renal Cell Carcinoma Receiving Nivolumab as Second-Line Therapy: A Multicentre Retrospective Cohort Study.
Sedat Biter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.